The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia

Autor: Milz R, Benson C, Knight K, Antunes J, Najarian D, Lopez Rengel PM, Wang S, Richarz U, Gopal S, Kane JM

Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 19, Pp 531-545 (2023)

Ruth Milz,1 Carmela Benson,1 Karl Knight,1 Jose Antunes,2 Dean Najarian,3 Paola-Maria Lopez Rengel,4 Steven Wang,1 Ute Richarz,5 Srihari Gopal,1 John M Kane6,7 1Janssen Research & Development LLC, Titusville, NJ, USA; 2Janssen-Cilag, Porto Salvo, Por

Externí odkaz: https://doaj.org/article/ccd96ec2994a4a2f87af066a413b68ba

Impact on functionality of the paliperidone palmitate three-month formulation in patients with a recent diagnosis of schizophrenia: a real-world observational prospective study.

Autor: Garcia-Portilla MP; Department of Psychiatry, University of Oviedo, CIBERSAM, Oviedo, Spain., Benito Ruiz A; Psychiatry Service, University Hospital Complex of Toledo, Toledo, Spain., Gómez Robina F; Psychiatry Service, Santa Teresa Hospital, Ávila, Spain., García Dorado M; Medical Department, Janssen Cilag, Madrid, Spain., López Rengel PM; Medical Department, Janssen Cilag, Madrid, Spain.

Publikováno v: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2022 Apr; Vol. 23 (5), pp. 629-638. Date of Electronic Publication: 2022 Jan 05.